MANUFACTURERS LIFE INSURANCE COMPANY, THE - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 193 filers reported holding MYRIAD GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$657,496
-13.0%
40,991
+25.7%
0.00%
Q2 2023$756,062
+1.5%
32,617
+1.7%
0.00%
Q1 2023$744,777
+60.8%
32,061
+0.4%
0.00%
Q4 2022$463,261
-23.5%
31,927
+0.5%
0.00%
Q3 2022$605,885
+2.9%
31,755
-2.0%
0.00%
Q2 2022$588,944
-29.0%
32,413
-1.5%
0.00%
-100.0%
Q1 2022$829,030
-25.0%
32,898
-17.9%
0.00%0.0%
Q4 2021$1,106,000
-14.8%
40,078
-0.3%
0.00%0.0%
Q3 2021$1,298,000
-1.8%
40,203
-7.0%
0.00%0.0%
Q2 2021$1,322,000
+7.8%
43,239
+7.4%
0.00%0.0%
Q1 2021$1,226,000
+43.9%
40,248
-6.6%
0.00%0.0%
Q4 2020$852,000
+55.8%
43,090
+2.8%
0.00%0.0%
Q3 2020$547,000
+15.9%
41,928
-2.0%
0.00%
Q2 2020$472,000
-27.0%
42,787
-5.4%
0.00%
-100.0%
Q1 2020$647,000
-43.4%
45,220
+7.7%
0.00%0.0%
Q4 2019$1,144,000
-7.0%
42,005
-2.8%
0.00%0.0%
Q3 2019$1,230,000
+1.3%
43,217
-1.1%
0.00%0.0%
Q2 2019$1,214,000
-18.6%
43,687
-2.8%
0.00%
-50.0%
Q1 2019$1,491,000
+23.7%
44,931
+8.3%
0.00%0.0%
Q4 2018$1,205,000
-39.1%
41,474
-3.6%
0.00%0.0%
Q3 2018$1,979,000
+9.5%
43,018
-11.1%
0.00%0.0%
Q2 2018$1,808,000
+26.4%
48,387
-0.0%
0.00%0.0%
Q1 2018$1,430,000
-15.9%
48,390
-2.3%
0.00%0.0%
Q4 2017$1,701,000
-3.4%
49,513
+1.7%
0.00%0.0%
Q3 2017$1,761,000
+36.7%
48,681
-2.4%
0.00%0.0%
Q2 2017$1,288,000
+27.5%
49,876
-5.3%
0.00%
+100.0%
Q1 2017$1,010,000
+31.2%
52,649
+14.0%
0.00%0.0%
Q4 2016$770,000
-18.4%
46,201
+0.7%
0.00%0.0%
Q3 2016$944,000
-92.7%
45,878
-89.1%
0.00%
-95.0%
Q2 2016$12,865,000
-19.3%
420,452
-1.7%
0.02%
+42.9%
Q1 2016$15,938,000
-11.6%
427,750
+2.4%
0.01%
-17.6%
Q4 2015$18,026,000
+58.3%
417,641
+37.4%
0.02%
+41.7%
Q3 2015$11,390,000
-69.7%
303,886
-72.5%
0.01%
-73.3%
Q2 2015$37,595,000
-6.6%
1,106,077
-2.7%
0.04%
-11.8%
Q1 2015$40,237,000
+25.9%
1,136,652
+21.1%
0.05%
+10.9%
Q4 2014$31,956,000
-19.1%
938,227
-8.4%
0.05%
-20.7%
Q3 2014$39,492,000
-31.3%
1,023,921
-30.6%
0.06%
-33.3%
Q2 2014$57,452,000
+41835.8%
1,476,175
+36602.5%
0.09%
Q1 2014$137,000
+179.6%
4,022
+71.6%
0.00%
Q4 2013$49,000
-64.7%
2,344
-60.4%
0.00%
Q3 2013$139,000
-34.4%
5,916
-24.9%
0.00%
Q2 2013$212,0007,8740.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders